Halozyme Therapeutics (HALO) Stock Forecast & Price Target

HALO$100.27-0.40 -0.40%
BiotechnologyLarge CapValue StockGrowth StockHigh Quality
Compare
Market cap$11.43BEnterprise value$16.78BRevenue (TTM)$1.66BMarket positionTop 25%

Score

69
Bullish
Value
61
Quality
85
Growth
62

Halozyme Therapeutics, Inc. price target

HALO
Low$90.00
Average$110.00
High$130.00
Upside vs current price+9.7%

The average target of $110.00 is +9.7% versus the current HALO price of $100.27.

Halozyme Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy5
Hold2
Sell0
Strong sell0
ConsensusBuy

9 analysts cover HALO.

Halozyme Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Halozyme Therapeutics, Inc. keeps 2026 EPS $8.62, 2027 EPS $10.42, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$8.62$1.88B
2027$10.42$2.10B

Is Halozyme Therapeutics, Inc. a buy or sell?

Of the 9 analysts covering Halozyme Therapeutics, Inc., 7 rate it a buy (2 strong buy and 5 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The HALO consensus label is Buy, beside 7 buy-side ratings and 0 sell-side ratings.

The average target of $110.00 implies +9.7% versus the current price of $100.27.

the Halozyme Therapeutics, Inc. closes with 7 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Halozyme Therapeutics, Inc. forecast

Between the HALO low of $90.00 and the high of $130.00, the average target is $110.00.

From today's $100.27 print, the HALO average target is +9.7% away.

Most of the HALO coverage agrees: 7 of 9 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.

HALO has both upgrades (1) and downgrades (0) in the recent window.

HALO targets have been marked up: $130.00 across the last month versus $114.17 across the last quarter.

HALO coverage is thin at 9 analysts, and one revision moves the average.

Halozyme Therapeutics, Inc. forecast questions

What is the HALO price target?

The published range for HALO is $90.00 to $130.00, with an average of $110.00. That average is +9.7% versus the current price of $100.27.

Is Halozyme Therapeutics, Inc. a buy or sell?

Of the 9 analysts covering Halozyme Therapeutics, Inc., 7 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for HALO is 7 on the buy side, 2 at hold, and 0 on the sell side.

What is the EPS estimate for Halozyme Therapeutics, Inc.?

Analyst EPS estimates for Halozyme Therapeutics, Inc.: 2026 $8.62, 2027 $10.42.

What is the revenue estimate for Halozyme Therapeutics, Inc.?

Analyst revenue estimates for Halozyme Therapeutics, Inc.: 2026 $1.88B, 2027 $2.10B.

How many analysts cover HALO?

9 analysts cover HALO. Their consensus on HALO is Buy, across those 9.

HALO price $100.27 -0.40 -0.40%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener